Blue Horseshoe Stocks

Blue Horseshoe Stocks: Update on AEMD & More

Aethlon Medical, Inc. AEMD

Yesterday’s standout play was AEMD, a stock that we’ve been tracking since October 14th. Following that initial alert, we observed a low of .20 in AEMD, and after trading sideways for the remainder of last month, the stock has been gaining ground steadily over the past few weeks.

We re-flagged it in yesterday’s extended watchlist and witnessed a 27% intraday run from .562-.717 on approximately 10X the 3-month average trading volume. At its high mark of .717, AEMD was showing us an increase of 258% over the lows we observed barely a month ago.

The event that prompted us to originally begin following AEMD was during the height of the Ebola scare, when the company announced that its “Hemopurifier” blood-cleansing system was to be used to treat an Ebola patient overseas. This morning, we ‘re getting word that the patient (who was experiencing multiple organ failure at the time the treatment was administered) has now been discharged from the hospital. >>> FULL PR

It will be interesting to see the effect this news has on AEMD as we approach the holiday hiatus, which shortens this to a 3½ day trading week.

Petroleo Brasiliero S.A. (Petrobras) PBR -Options

PBR is gapping up again this morning, in the wake of yesterday’s announcement that its ‘Cidade de Ilhabela’ offshore oil platform had been brought online. (Read our comments on the company’s situation in yesterday’s report if you missed it)

Anyone who caught yesterday’s morning report will recall our options-trading targets; we were considering the Jan 17th $10 and $11 Calls. The gap-and-fade that followed provided us a good opportunity to snap up some discounted contracts, and we’ll be looking to lock in some profits on the gap-up we’re seeing this morning.

SinoCoking Coal and Coke Chemical Industries, Inc. SCOK

Another play that we’ve been monitoring for some time is SCOK, which we’ll want to watch closely today on the heels of a notable PR released this morning. According to SCOK, the syngas plant that it recently opened in China is now operating at 100% capacity and pulling more than $80K worth of syngas from the Earth per day.

We actually began tracking SCOK the morning it announced its intent to open the facility, (it ran hard that day from 3.35-9.37, +180%) so this morning’s PR regarding the plant acheiving full operational status brings us full circle with SCOK.

PINGDINGSHAN, China, Nov. 25, 2014 (GLOBE NEWSWIRE) — SinoCoking Coal and Coke Chemical Industries, Inc. (SCOK), a producer of clean energy products located in Henan Province, today announced that its above ground facility for the conversion of carbon dioxide into clean-burning syngas has achieved its initial production target of 25,000 cubic meters per hour and is currently transporting syngas to three customers and agents in and around its facility in Pingdingshan.

Based on the current price of $0.139 per cubic meter for syngas, the gross revenue generated per day by the aboveground facility is approximately $83,280. Gross profit margin is expected to be between 45% and 50%. >> FULL PR

Extended Watchlist:
ISNS, LAKE, CAMT, DRWI, LIVE

Blue Horseshoe Stocks: Commenting on PBR & More

Petroleo Brasiliero S.A. (Petrobras) PBR

Amid allegations of money-laundering and bribery which extend high up into the Brazilian government (including former PBR board member and President Dilma Rousseff) the sixth-largest energy company in the world, and a point of focus for us all year, could be forced to write down billions in assets and reduce dividends. The company’s Q3 financials are being delayed indefinitely as a result.

The long-term implications of such a scandal are too vast and varied for us to make even a brief assessment accurately. What we can do is stay extra tuned to the PBR newsfeed to stay as up-to-date as possible on current events and adhere to our technicals, because we can still see potential on the chart.

On Tuesday, PBR hit its all-time low of 8.80. but has since made higher lows and higher highs over the proceeding sessions. After we tagged it on Friday morning, there was a 9% intraday move from 10.08 to $11, and this morning the premarket high is 11.51, which will act as immediate resistance as the session kicks off. We’ll want to see support hold at roughly 10.85, but if PBR can break past this morning’s high to confirm its continued uptrend, the next thing we’d be looking for is the filling of a gap on the chart from approximately $12-12.50.

As far as options go, we’re presently looking at the Jan 17th $10 and $11 Calls, provided the current trend continues.

Prosensa Holdings (N.V.) RNA

RNA is a stock that we tracking periodically this spring and summer, and we just wanted to comment quickly on the buyout offer the company announced this morning. In a $680M deal, Prosensa will receive around $17.75/share from buyer BioMarin Pharmaceutical.

Following an alert we put out on RNA back in May, the stock was trading at a low of 7.96; this morning’s premarket high of $19 means we’ve seen more than a 130% move in this play over a span of about 5 months.

Extended Watchlist:
MOLG, GERN, CIMT, SYN, AEMD, MY

Blue Horseshoe Stocks: Recapping RPI & JNUG

Roberts Realty Investors, Inc. RPI

RPI was a standout from yesterday’s extended watchlist; it began the day trading at an early low of .86 before gradually building throughout the session to a high of 1.16. The move marked the chance at up to 38% in intraday gains for us, and came on substantial volume to the tune of 36X the 3-month average.

The move came following a PR on Wednesday that iterated the details of a purchase agreement with A-III Investment Partners LLC, whereby the company intends to purchase $12M worth of RPI, giving a tentative execution price estimate of 1.40/share. >>> Full PR

For that reason, we will allow RPI to remain on our watchlist for the time being. A move to the figure mentioned in Wednesday’s PR would mean added gains of more than 35% from the present level.

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

JNUG continued to perform well for us following its inclusion in yesterday’s report, making a modest yet notable 13% intraday move from a low of 4.86 and peaking at 5.50. This ETF has offered us the chance at several swing trade opportunities in the weeks since we first began tracking it in October, and like we said yesterday, will remain of interest as we approach a time of year when worldwide gold demand is generally at a high level.

We’re seeing a significant gap-up this morning as well into the 5.80-range. The recent low we’ve seen from JNUG came on November 5th at 2.84, meaning that in a span of just over two weeks, we’ve already witnessed a greater-than 100% increase.

Extended Watchlist:
JRJC, AMZN, FB, GPRO, PBR

Blue Horseshoe Stocks: Momentum Mover & More

True 2 Beauty, Inc. TRTB

TRTB is a momentum play that caught our attention when it began to break out during yesterday’s session. The characteristics of this high-flyer have us on alert for the possibility of continued upward movement, and a subsequent dip-and-rip situation. The stock has a low float, and as we know, that type of structure can give way to surges in buying pressure such as those that are fed by heavy momentum.

This stock virtually exploded yesterday, so it’s going to be very interesting to see how trading action resumes today. With such rapid movement, it wouldn’t be surprising to see significant bounce opportunities once it pulls back from these monstrous initial gains and begins to rebound.

Side Note: TRTB was actually tied to another stock that has appeared in our reports, APDN. Last month the two companies announced a collaboration agreement to develop a DNA-based authentication solution (Read Joint PR) A quick tag search for APDN on our blog shows that we began tracking this stock years ago, going all the way back to the summer of 2012 when the stock was trading below .10. The company just completed an uplisting to the NASDAQ, and is currently trading in the 2.70-range.

Direxion Daily Jr Gld Mnrs Bull 3X ETF (JNUG)

We’ve been continuously tracking JNUG for several weeks now; on Tuesday, after tagging the play in our extended watchlist, we witnessed a 15% increase from 5.29-6.09.

Yesterday brought forth a consolidation to a morning low of 4.83, and a subsequent intraday snap-back to 5.80 (+20%) and then continued to consolidate into the close, and this morning it appears to be gapping up above the $5-mark.

We’ll be keeping a close eye on JNUG moving forward; despite the dollar being at 5-year highs, supply and demand still play a large role in gold price action, and from October-January with the Indian Celebration of Diwali and Chinese New Year coming up, demand for gold will be pushed to high levels.

Extended Watchlist:
NVAX, MAGS, ANV, IAG, RPI

Blue Horseshoe Stocks: Revisiting PSID

PositiveID Corp. PSID

We’ve got a lengthy history with this morning’s topic of discussion, PSID, which dates all the way back to 2013. Early this year, we tracked this play over an impressive range from .0572 to .125 over a short time period in late February to early March. That move gave us the chance to bag gains close to 120%

Recently, the chart has shown some rapid swings in the .03-.085 range, and after coming down to find support at .034 last week the stock is beginning to look like it’s in a good position to bounce again, but before we break down the PSID chart let’s recap what the company does.

For those who might not remember, PSID has hung its hat on a couple of key products:

M-BAND – PSID’s M-BAND Detector, in a nutshell, is a bio-aerosol device that uses cell lysis and nucleic acid purification to provide continuous analysis of air quality. The M-BAND screens for bacteria, viruses, and other bio-toxins.This pathogen detector has already been tested in the field. The company recently shipped several units to Maryland for continued testing to protect U.S. warfighters as part of The Joint United States Forces Korea Portal and Integrated Threat Recognition (JUPITR) program >>> Read PR

Firefly Dx – This is PSID’s point-of-care diagnostic tool still under development. It’s a portable handheld device capable of sample lysis, purification, PCR analysis in the field. The ultimate goal is to provide point-of-care diagnostics in 20 minutes or less with a device that could essentially fit in your pocket. Due to the nature of PSID‘s products, it’s not a surprise that the recent Ebola scare drove this stock to spike violently last month. In the time since then, we’ve learned that the company is working with U.S. Special Operations Command in hopes of continuing the development of the Firefly Dx system and bringing it into the realm of real-world use. >>> Read PR

TODAY’S NEWS:

This morning the company released both Quarterly and 9-Month financials, the highlights of which included reported revenue of $325,000 for the quarter ended 09/30/14, and $745,000 for the 9 months ended 09/30/14. PSID also increased its 2014/2015 revenue and backlog estimate to $3.6 million, and reiterated its revenue guidance of $4-10 million through the end of 2015 (2014 and 2015 combined) >> Read PR

CHART:

As we said earlier regarding the PSID chart, we can see a lot of potential in its current positioning. It’s coming off of support, with the RSI approaching the 50-line and a MACD that appears to be ready to undergo a bullish cross. We want to have PSID at the top of our watchlists as it has shown us its ability to make rapid gains on multiple occasions. Go ahead and check out the video presentation we prepared on the PSID chart below:

More Info @ PositiveIDcorp.com